| 32.04 Data as of Jun 18 |  +0.54 / +1.71%Today’s Change | 14.50 Today|||52-Week Range 33.93 | +66.70% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $9.7B |
Company Description
Olympus Corp. is engaged in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical Systems, Life Science and Industrial, Imaging Systems, Information and Communication, and Others. The Medical Systems segment covers endoscopes, and endoscopic surgery and therapy. The Life Science and Industrial segment manufactures and sells biological and industrial microscopes, industrial endoscopes, non-destructive testing equipment, and printers. The Imaging Systems segment deals with digital cameras and recording devices. The Information and Communication segment sells mobile terminals such as mobile phones. The Others segment includes biomaterial manufacturing and sales, and system development. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
Employees
Shareholders
| Other institutional | 0.02% |
| Mutual fund holders | 0.00% |
| Individual stakeholders | -- |
Top Executives
| Hiroyuki Sasa | President, CEO & Representative Director |
| Akira Kubota | Executive Officer, Group President-Corporate R&D |
| Nobuhiro Abe | Executive Officer |
| Masamichi Handa | Executive Officer |
| Koichi Karaki | Executive Officer |
.
